Managing scientific uncertainty in medical decision making: the case of the Advisory Committee on Immunization Practices

Publicaciones científicas
 
Estados Unidos
Título(s) original(es)
Managing scientific uncertainty in medical decision making: the case of the Advisory Committee on Immunization Practices
Autor(es)
J Michael Martinez
Fuente(s)
Journal of Medicine and Philosophy
Año de publicación
2012

Descripción

Article published in the Journal of Medicine and Philosophy, Volume 37, Issue 1, Pages 6-27, February 2012. This article explores the question of how scientific uncertainty can be managed in medical decision making using the Advisory Committee on Immunization Practices as a case study. It concludes that where a high degree of technical consensus exists about the evidence and data, decision makers act according to a clear decision rule. If a high degree of technical consensus does not exist and uncertainty abounds, the decision will be based on a variety of criteria, including readily available resources, decision-process constraints, and the available knowledge base, among other things. Decision makers employ a variety of heuristic devices and techniques, thereby employing a pragmatic approach to uncertainty in medical decision making. The article concludes with recommendations for managing scientific uncertainty in medical decision making. This document is accessible to subscribers; otherwise it can be purchased online.

Noticias y eventos relacionados

  • Estados Unidos

    ACIP releases the 2017 adult and childhood immunization schedules

    06.02.2017

    The CDC and its Advisory Committee on Immunization Practices (ACIP), together with the AAFP and other medical professional organizations, have released the 2017 adult and childhood immunization schedules.

    Leer más
  • Estados Unidos

    CDC Advisory Committee On Immunization Practices Votes To Recommend Vaxchora, PaxVax’s Single-Dose Oral Cholera Vaccine

    27.06.2016

    The ACIP voted unanimously at their June 22 meeting to recommend Vaxchora for the prevention of toxigenic Vibrio cholerae O1 for travelers to areas of active cholera transmission. The Category A recommendation made by the ACIP for Vaxchora will be forwarded to the director of the CDC and the U.S. Department of Health and Human Services for review and approval. Once approved, the recommendations will be published in the Morbidity and Mortality Weekly Report (MMWR). Category A recommendations are made for all persons in an age- or risk-factor-based group.

    Leer más
  • Estados Unidos

    ACIP recommends not to use LAIV During 2016-17 Flu Season

    24.06.2016

    The CDC's Advisory Committee on Immunization Practices (ACIP) held its meeting on June 22-23, 2016. Influenza was on the agenda and ACIP voted to recommend that live attenuated influenza vaccine (LAIV; FluMist), which is licensed for use in people ages 2-49 years, should not be used during the 2016-17 flu season.

    Leer más